Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(13):1001-1003; doi:10.1093/jnci/95.13.1001
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by MacKenzie, J.
Right arrow Articles by Jarrett, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacKenzie, J.
Right arrow Articles by Jarrett, R. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 95, No. 13, 1001-1003, July 2, 2003
© 2003 Oxford University Press

BRIEF COMMUNICATION

Association Between Simian Virus 40 DNA and Lymphoma in the United Kingdom

Jane MacKenzie, Katherine S. Wilson, Jacqueline Perry, Alice Gallagher, Ruth F. Jarrett

Affiliation of authors: Leukaemia Research Fund Virus Centre, Institute of Comparative Medicine, University of Glasgow, Glasgow, U.K.

Correspondence to: Ruth F. Jarrett, M.B., Ch.B., F.R.C. Path., F.R.C.P. (Glasg.) Department of Veterinary Pathology, Faculty of Veterinary Medicine, University of Glasgow, Bearsden Rd., Glasgow G61 1QH, U.K. (e-mail: r.f.jarrett{at}vet.gla.ac.uk).

ABSTRACT

Recent studies have reported the presence of simian virus 40 (SV40) DNA sequences in approximately 40% of tumor samples from non-Hodgkin’s lymphoma (NHL) patients from the United States. We examined a series of 259 tumor and blood samples, including 152 NHL samples, from patients in the U.K. with lymphadenopathy and lymphoid leukemia for the presence of SV40 DNA using a highly sensitive quantitative polymerase chain reaction (PCR) assay and a consensus PCR assay capable of detecting the polyomaviruses SV40, BK, and JC. SV40 DNA sequences were not detected in any sample using either assay. Because the incidence of NHL is similar in the U.K. and the United States, this finding suggests that SV40 is unlikely to have an etiologic role in NHL.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Microbiol.Home page
T. J. Dumonceaux, C. Mesa, and A. Severini
Internally Controlled Triplex Quantitative PCR Assay for Human Polyomaviruses JC and BK
J. Clin. Microbiol., September 1, 2008; 46(9): 2829 - 2836.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. L. Poulin and J. A. DeCaprio
Is There a Role for SV40 in Human Cancer?
J. Clin. Oncol., September 10, 2006; 24(26): 4356 - 4365.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
D. E. Rollison, E. A. Engels, N. A. Halsey, K. V. Shah, R. P. Viscidi, and K. J. Helzlsouer
Prediagnostic Circulating Antibodies to JC and BK Human Polyomaviruses and Risk of Non-Hodgkin Lymphoma.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 543 - 550.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
D. E. Rollison, K. J. Helzlsouer, N. A. Halsey, K. V. Shah, and R. P. Viscidi
Markers of Past Infection with Simian Virus 40 (SV40) and Risk of Incident Non-Hodgkin Lymphoma in a Maryland Cohort
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1448 - 1452.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. J. Manfredi, J. Dong, W.-j. Liu, L. Resnick-Silverman, R. Qiao, P. Chahinian, M. Saric, A. R. Gibbs, J. I. Phillips, J. Murray, et al.
Evidence against a Role for SV40 in Human Mesothelioma
Cancer Res., April 1, 2005; 65(7): 2602 - 2609.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
J Sabatier, E Uro-Coste, A Benouaich, S Boetto, M Gigaud, M Tremoulet, M-B Delisle, F Galateau-Salle, and P Brousset
Immunodetection of SV40 large T antigen in human central nervous system tumours
J. Clin. Pathol., April 1, 2005; 58(4): 429 - 431.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. A. Engels, J. Chen, P. Hartge, J. R. Cerhan, S. Davis, R. K. Severson, W. Cozen, and R. P. Viscidi
Antibody Responses to Simian Virus 40 T Antigen: A Case-Control Study of Non-Hodgkin Lymphoma
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 521 - 524.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. A. Engels, R. P. Viscidi, D. A. Galloway, J. J. Carter, J. R. Cerhan, S. Davis, W. Cozen, R. K. Severson, S. de Sanjose, J. S. Colt, et al.
Case-Control Study of Simian Virus 40 and Non-Hodgkin Lymphoma in the United States
J Natl Cancer Inst, September 15, 2004; 96(18): 1368 - 1374.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
D. E. M. Rollison, W. F. Page, H. Crawford, G. Gridley, S. Wacholder, J. Martin, R. Miller, and E. A. Engels
Case-Control Study of Cancer among US Army Veterans Exposed to Simian Virus 40-contaminated Adenovirus Vaccine
Am. J. Epidemiol., August 15, 2004; 160(4): 317 - 324.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
R. A. Vilchez and J. S. Butel
Emergent Human Pathogen Simian Virus 40 and Its Role in Cancer
Clin. Microbiol. Rev., July 1, 2004; 17(3): 495 - 508.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Shivapurkar, T. Takahashi, J. Reddy, Y. Zheng, V. Stastny, R. Collins, S. Toyooka, M. Suzuki, G. Parikh, S. Asplund, et al.
Presence of Simian Virus 40 DNA Sequences in Human Lymphoid and Hematopoietic Malignancies and Their Relationship to Aberrant Promoter Methylation of Multiple Genes
Cancer Res., June 1, 2004; 64(11): 3757 - 3760.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.